摘要
目的探讨血清CA125在妇科疾病中的应用价值。方法采用放射免疫分析法测定100例妇科疾病患者CA125抗原水平。结果卵巢上皮癌组CA125水平为(641.47±199.49)μg/L,该组经手术和化疗后CA125水平比治疗前显著降低(P<0.01);子宫内膜异位症组及子宫腺肌症组CA125水平明显高于卵巢良性肿瘤及子宫肌瘤。结论血清CA125水平测定对卵巢上皮癌的诊断及预后评估具有重要意义,在子宫内膜异位症及子宫腺肌症诊断中有一定价值。
Objective To evaluate the effects of serum CA125 in the gynecological patients. Methods Detum CA125 of 100 cases was determined with radioimmunoassay. Results The levels of serum CA125 were 641.47～199.49ug/l in patients with epithelial ovarian cancer, After successful eytoreduetive surgery and chemotherapy for patients with epithelial ovarian cancer, the CA125 value was significantly dropped （P〈0.01）. The levels of CA125 in the patients with endometriosis and adenomyosis are obviously higher than that in the patients with benign tumor and uterine myoma. Conclusion In conjunction with other clinical data including symptoms and signs, serum CA125 assay is of great help in diagnosis for patients with epithelial ovarian cancer. There was definitive value in diagnosis of endometriosis and adenomyosis by determing serum CA125.
出处
《中国热带医学》
CAS
2005年第6期1276-1277,共2页
China Tropical Medicine
基金
2005-04-04
